Lixte Biotechnology
LIXT
LIXT
10 hedge funds and large institutions have $2.52M invested in Lixte Biotechnology in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
43% less capital invested
Capital invested by funds: $4.43M → $2.52M (-$1.91M)
Holders
10
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$78K | |
| 2 | +$18.4K | |
| 3 | +$7.44K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$4.22K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4K |
Top Sellers
| 1 | -$366K | |
| 2 | -$199K | |
| 3 | -$154K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38K |